The US FTC announces it will ramp up enforcement against illegal rebate schemes and bribes to prescription drug middleman that block cheaper drugs

FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs* Agency puts drug industry on notice that paying rebates and fees to exclude competitors offering lower-cost drug alternatives can violate competition and consumer protection laws The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The enforcement policy statement issued today puts drug companies and prescription drug middlemen on notice that paying rebates and fees to exclude

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

US Federal Trade Commission, The US FTC announces it will ramp up enforcement against illegal rebate schemes and bribes to prescription drug middleman that block cheaper drugs, 16 June 2022, e-Competitions July 2022, Art. N° 107119

Visites 55

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues